MuGard is a new, effective, mucoadhesive oral protectant, developed by Access Pharmaceuticals, Inc., that is designed to form a protective hydrogel coating over the oral mucosa while a patient is undergoing chemotherapy and/or radiotherapy cancer treatments to the head and neck.
MuGard shields the tender membranes of the mouth and tongue, and provides instant numbing and protection against oral mucositis, a painful and common side effect of cancer therapy. As a ready-to-use oral mucositis mouth rinse, MuGard is convenient and easy to use.
FIRST DAY EVERY DAY
In two separate comparisons, it was shown that mean oral mucositis scores were lower for patients using MuGard than for similar patients on standard care. One of the most striking features of the comparison is that 43% of patients on MuGard experienced no oral mucositis compared with only 7% in the historical control group.
Is MuGard Right for me?
Oral mucositis is a significant health issue for all cancer patients receiving radiotherapy and chemotherapy, especially head and neck cancer patients, and those who receive highly mucotoxic chemotherapy regimens like 5FU and many others.
No comments:
Post a Comment